BLM induces pulmonary inflammation and PF within a short time, while BLM administered intratracheally up-regulates fibrotic factor levels, like IL-1β, IL-6, TNF-α, and TGF-β, etc. [21]. The gene discussed is IL1B; the disease is inflammation.